Affiliation:
1. Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts
Abstract
ABSTRACT
Humans have two nearly identical copies of the
Survival Motor Neuron
(
SMN
) gene,
SMN1
and
SMN2
. In spinal muscular atrophy (SMA),
SMN2
is not able to compensate for the loss of
SMN1
due to exclusion of exon 7. Here we describe a novel inhibitory element located immediately downstream of the 5′ splice site in intron 7. We call this element intronic splicing silencer N1 (ISS-N1). Deletion of ISS-N1 promoted exon 7 inclusion in mRNAs derived from the
SMN2
minigene. Underlining the dominant role of ISS-N1 in exon 7 skipping, abrogation of a number of positive
cis
elements was tolerated when ISS-N1 was deleted. Confirming the silencer function of ISS-N1, an antisense oligonucleotide against ISS-N1 restored exon 7 inclusion in mRNAs derived from the
SMN2
minigene or from endogenous
SMN2
. Consistently, this oligonucleotide increased the levels of SMN protein in SMA patient-derived cells that carry only the
SMN2
gene. Our findings underscore for the first time the profound impact of an evolutionarily nonconserved intronic element on
SMN2
exon 7 splicing. Considering that oligonucleotides annealing to intronic sequences do not interfere with exon-junction complex formation or mRNA transport and translation, ISS-N1 provides a very specific and efficient therapeutic target for antisense oligonucleotide-mediated correction of
SMN2
splicing in SMA.
Publisher
American Society for Microbiology
Subject
Cell Biology,Molecular Biology
Cited by
379 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献